Literature DB >> 23157580

Antigen 85A and mycobacterial DNA-binding protein 1 are targets of immunoglobulin G in individuals with past tuberculosis.

Mayuko Osada-Oka1, Yoshitaka Tateishi, Yukio Hirayama, Yuriko Ozeki, Mamiko Niki, Seigo Kitada, Ryoji Maekura, Kunio Tsujimura, Yukio Koide, Naoya Ohara, Taro Yamamoto, Kazuo Kobayashi, Sohkichi Matsumoto.   

Abstract

Development of accurate methods for predicting progression of tuberculosis (TB) from the latent state is recognized as vitally important in controlling TB, because a majority of cases develop from latent infections. Past TB that has never been treated has a higher risk of progressing than does latent Mycobacterium tuberculosis infection in patients who have previously received treatment. Antibody responses against 23 kinds of M. tuberculosis proteins in individuals with past TB who had not been medicated were evaluated. These individuals had significantly higher concentrations of antibodies against Antigen 85A and mycobacterial DNA-binding protein 1 (MDP1) than did those with active TB and uninfected controls. In addition, immunohistochemistry revealed colocalization of tubercle bacilli, antigen 85 and MDP1 inside tuberculous granuloma lesions in an asymptomatic subject, showing that M. tuberculosis in lesions expresses both antigen 85 and MDP1. Our study suggests the potential usefulness of measuring antibody responses to antigen 85A and MDP1 for assessing the risk of TB progression.
© 2013 The Societies and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23157580     DOI: 10.1111/j.1348-0421.2012.12005.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Difference in Antibody Responses to Mycobacterium tuberculosis Antigens in Japanese Tuberculosis Patients Infected with the Beijing/Non-Beijing Genotype.

Authors:  Jingge Zhao; Beata Shiratori; Masao Okumura; Hideki Yanai; Makoto Matsumoto; Chie Nakajima; Kazue Mizuno; Kenji Ono; Tetsuya Oda; Haorile Chagan-Yasutan; Yugo Ashino; Takashi Matsuba; Takashi Yoshiyama; Yasuhiko Suzuki; Toshio Hattori
Journal:  J Immunol Res       Date:  2017-01-15       Impact factor: 4.818

2.  Longitudinal Evaluation of Humoral Immunity and Bacterial and Clinical Parameters Reveals That Antigen-Specific Antibodies Suppress Inflammatory Responses in Active Tuberculosis Patients.

Authors:  Mamiko Niki; Takashi Yoshiyama; Yuji Miyamoto; Masao Okumura; Makoto Niki; Ken-Ichi Oinuma; Yukihiro Kaneko; Sohkichi Matsumoto; Yuka Sasaki; Hideo Ogata; Hajime Goto; Shoji Kudoh; Yoshihiko Hoshino
Journal:  J Immunol Res       Date:  2018-07-04       Impact factor: 4.818

3.  Serum antibody profiles in individuals with latent Mycobacterium tuberculosis infection.

Authors:  Ryoji Maekura; Seigo Kitada; Mayuko Osada-Oka; Yoshitaka Tateishi; Yuriko Ozeki; Takeya Fujicawa; Mari Miki; Ogawa Jyunnko; Masahide Mori; Sohkichi Matsumoto
Journal:  Microbiol Immunol       Date:  2019-04-09       Impact factor: 1.955

Review 4.  An Inflammatory Story: Antibodies in Tuberculosis Comorbidities.

Authors:  Milla R McLean; Lenette L Lu; Stephen J Kent; Amy W Chung
Journal:  Front Immunol       Date:  2019-12-09       Impact factor: 7.561

5.  Metabolic adaptation to glycolysis is a basic defense mechanism of macrophages for Mycobacterium tuberculosis infection.

Authors:  Mayuko Osada-Oka; Nobuhito Goda; Hiroyuki Saiga; Masahiro Yamamoto; Kiyoshi Takeda; Yuriko Ozeki; Takehiro Yamaguchi; Tomoyoshi Soga; Yu Tateishi; Katsuyuki Miura; Daisuke Okuzaki; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  Int Immunol       Date:  2019-11-08       Impact factor: 4.823

6.  Direct Attachment with Erythrocytes Augments Extracellular Growth of Pathogenic Mycobacteria.

Authors:  Yukiko Nishiuchi; Yoshitaka Tateishi; Hiroshi Hirano; Yuriko Ozeki; Takehiro Yamaguchi; Mari Miki; Seigo Kitada; Fumito Maruyama; Sohkichi Matsumoto
Journal:  Microbiol Spectr       Date:  2022-03-16

7.  Evaluation of Humoral Immunity to Mycobacterium tuberculosis-Specific Antigens for Correlation with Clinical Status and Effective Vaccine Development.

Authors:  Mamiko Niki; Maho Suzukawa; Shunsuke Akashi; Hideaki Nagai; Ken Ohta; Manabu Inoue; Makoto Niki; Yukihiro Kaneko; Kozo Morimoto; Atsuyuki Kurashima; Seigo Kitada; Sohkichi Matsumoto; Koichi Suzuki; Yoshihiko Hoshino
Journal:  J Immunol Res       Date:  2015-10-19       Impact factor: 4.818

8.  Significance of a histone-like protein with its native structure for the diagnosis of asymptomatic tuberculosis.

Authors:  Yukiko Ohara; Yuriko Ozeki; Yoshitaka Tateishi; Tsukasa Mashima; Fumio Arisaka; Yasuo Tsunaka; Yoshie Fujiwara; Akihito Nishiyama; Yutaka Yoshida; Kengo Kitadokoro; Haruka Kobayashi; Yukihiro Kaneko; Ichiro Nakagawa; Ryoji Maekura; Saburo Yamamoto; Masato Katahira; Sohkichi Matsumoto
Journal:  PLoS One       Date:  2018-10-25       Impact factor: 3.240

9.  Monitoring IgG against Mycobacterium tuberculosis proteins in an Asian elephant cured of tuberculosis that developed from long-term latency.

Authors:  Satoshi Ishikawa; Yuriko Ozeki; Satomi Suga; Yasuhiko Mukai; Haruka Kobayashi; Erina Inouchi; Shaban A Kaboso; Gebremichal Gebretsadik; Desak Nyoman Surya Suameitria Dewi; Akihito Nishiyama; Yoshitaka Tateishi; Hayato Takihara; Shujiro Okuda; Shiomi Yoshida; Naoaki Misawa; Sohkichi Matsumoto
Journal:  Sci Rep       Date:  2022-03-12       Impact factor: 4.379

10.  Characteristic profile of antibody responses to PPD, ESAT-6, and CFP-10 of Mycobacterium tuberculosis in pulmonary tuberculosis suspected cases in Surabaya, Indonesia.

Authors:  Desak Nyoman Surya Suameitria Dewi; Ni Made Mertaniasih; Yuriko Ozeki; Wayan Tunas Artama; Mamiko Niki; Yoshitaka Tateishi; Manabu Ato; Sohkichi Matsumoto
Journal:  Braz J Infect Dis       Date:  2019-08-14       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.